Showing results (51-60 of 192) with videos related to
Sort By:
Pageof 20
Circulation. Cardiovascular Genetics|April 3, 2013
MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarctionYvan Devaux, Melanie Vausort, Gerry P McCann, et al.Food & Function|June 21, 2024
Biomarkers of food intake and their relevance to metabolic syndromeMiguel Cifuentes, Farhad Vahid, Yvan Devaux, et al.Trends in Molecular Medicine|June 14, 2022
Methodological considerations for circulating long noncoding RNA quantificationDavid de Gonzalo-Calvo, Miron Sopić, Yvan Devaux, et al.Clinical Chemistry and Laboratory Medicine|May 15, 2024
Navigating the path of reproducibility in microRNA-based biomarker research with ring trialsMiron Sopić, Yvan Devaux, David de Gonzalo-CalvoInternational Journal of Molecular Sciences|January 25, 2020
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and CardioprotectionBranislav Kura, Barbora Kalocayova, Yvan Devaux, et al.Clinical Chemistry|January 19, 2012
Use of circulating microRNAs to diagnose acute myocardial infarctionYvan Devaux, Mélanie Vausort, Emeline Goretti, et al.Journal of Cardiac Failure|April 3, 2012
Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarctionYvan Devaux, Melanie Vausort, Francisco Azuaje, et al.Antioxidants & Redox Signaling|July 13, 2017
Long Noncoding RNAs and Cardiac DiseaseSimona Greco, Antonio Salgado Somoza, Yvan Devaux, et al.The Journal of Biological Chemistry|January 17, 2003
p21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor-mediated inhibition of oxidant-induced cell deathYunbiao Lu, Zhong-Zong Pan, Yvan Devaux, et al.International Journal of Cardiology. Heart & Vasculature|November 22, 2017
The circular RNA MICRA for risk stratification after myocardial infarctionAntonio Salgado-Somoza, Lu Zhang, Melanie Vausort, et al.Pageof 20